Not yet recruiting
Clinical Trial of TB511 in Advanced Solid Tumors
NCT06400160
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +27 more
- Locations
-
Not specified
Clinical trial condition
NSCLC
Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.
367 public trials
125 recruiting studies
NSCLC trial results
Not yet recruiting
Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC
NCT07231575
- Conditions
- Chemo-free Therapy, NSCLC, Neoadjuvant Immunotherapy
- Locations
-
Not specified
Not yet recruiting
A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
NCT07198321
- Conditions
- CRC (Colorectal Cancer), Cancer, Colonic Diseases, +12 more
- Locations
-
- Sun-Yat sen university cancer center Guangzhou, Guangdong, China
NCT07179445
- Conditions
- NSCLC
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital(Lead Center) Tianjin, China
Not yet recruiting
Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
NCT07156604
- Conditions
- NSCLC, Neoadjuvant Therapy
- Locations
-
- Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Not yet recruiting
Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer
NCT07153770
- Conditions
- MET Activating Mutation, MET Exon 14 Mutation, NSCLC
- Locations
-
Not specified
Not yet recruiting
QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC
NCT07134413
- Conditions
- NSCLC
- Locations
-
Not specified
Not yet recruiting
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
NCT07086326
- Conditions
- AK112, Bispecific Antibody, Immunotherapy, +2 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Hunan Cancer Hospital Changsha, Hunan, China
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
- The First Affiliated Hospital of Xi'an Jiaotong University Xi’an, Shanxi, China
Not yet recruiting
Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
NCT05909137
- Conditions
- Immunotherapy, Intensity Modulated Radiation Therapy, NSCLC, +1 more
- Locations
-
Not specified
Not yet recruiting
Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
NCT07035392
- Conditions
- Adebrelimab (SHR-1316), Chemotherapy, NSCLC
- Locations
-
Not specified